Monte Carlo dosimetry modeling of focusedkVx‐ray radiotherapy of eye diseases with potential nanoparticle dose enhancement

Authors:

Abstract
Purpose: Eye plaque brachytherapy is the most common approach for intraocular cancer treatment. It is, however, invasive and subject to large setup uncertainty due to the surgical operation. We propose a novel‐focusedkVx‐ray technique with potential nanoparticle (NP) enhancement and evaluate its application in treating choroidal melanoma and iris melanoma by Monte Carlo (MC) dosimetry modeling.Methods: A polycapillary x‐ray lens was used to focus 45kVp x rays to achieve pinpoint accuracy of dose delivery to small tumors near critical structures. In addition to allowing for beam focusing, the use ofkVx rays takes advantage of the strong photoelectric absorption of metallicNPs in that energy regime and hence strong radiosensitization. We constructed anMCsimulation program that takes into account the x‐ray optic modeling and usedGEANT4 for dosimetric calculation. Extensive phantom measurements using a prototype‐focused x‐ray system were carried out. TheMCsimulation of simple geometry phantom irradiation was first compared to measurements to verify the x‐ray optic lens modeling in conjunction with the Geant4 dosimetric calculation. To simulate tumor treatment, a geometric eye model and two tumor models were constructed. Dose distributions of the simulated treatments were then calculated.NPradiosensitization was also simulated for two concentrations of 2 nm goldNP(AuNP) uniformly distributed in the tumor.Results: TheMC‐simulated full width at half maximum (FWHM) and central‐axis depth dose of the focusedkVx‐ray beam match those measured onEBT3 films within ~10% around the depth of focus of the beam. Dose distributions of the simulated ocular tumor treatments show that focused x‐ray beams can concentrate the high‐dose region in or close to the tumor plus margin. For the simulated posterior choroidal tumor treatment, with sufficient tumor coverage, the doses to the optic disc and fovea are substantially reduced with focused x‐ray therapy compared to eye plaque treatment (3.8 vs 39.8 Gy and 11.1 vs 53.8 Gy, respectively). The eye plaque treatment was calculated using an Eye Physics plaque with I‐125 seeds underTG43 assumption. For the energy spectrum used in this study, the average simulated dose enhancement ratios (DERs) are roughly 2.1 and 1.1 for 1.0% and 0.1% AuNPmass concentration in the tumor, respectively.Conclusion: Compared to eye plaque brachytherapy, the proposed focusedkVx‐ray technique is noninvasive and shows great advantage in sparing healthy critical organs without sacrificing the tumor control. TheNPradiation dose enhancement is considerable at our proposedkVrange even with a lowNPconcentration in the tumor, providing better critical structure protection and more flexibility for treatment planning.
Funding Information
  • Elsa U. Pardee Foundation

This publication has 52 references indexed in Scilit: